The Patent Finder

Valerio Therapeutics

6 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Onxeo (to 2023)

0
Ending by 2030
Jun 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 30, 2027
    The maintenance fee for Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates (US 10,363,317) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Use of a Combination of Dbait Molecule and Parp Inhibitors to Treat Cancer (US 10,563,197) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

PatentTitleStatus Expires Confidence
US 9,428,538Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates
In force
 · Medium confidence
In forceMedium confidence
US 10,363,317Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates
In force
 · Medium confidence
In forceMedium confidence
US 10,765,758Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates
In force
 · Medium confidence
In forceMedium confidence
US 10,563,197Use of a Combination of Dbait Molecule and Parp Inhibitors to Treat Cancer
In force
 · High confidence
In forceHigh confidence
US 10,821,128Treatment of Cancer by Systemic Administration of Dbait Molecules
In force
 · High confidence
In forceHigh confidence
US 12,790,616New Conjugated Nucleic Acid Molecules and Their Uses
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 6: 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

Every application published under this name has become a patent.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited